Histone Deacetylase 7 Associates with Hypoxia-inducible Factor 1alpha and Increases Transcriptional Activity
Overview
Affiliations
Hypoxia-inducible factor (HIF)-1alpha is a transcription factor that controls expression of genes responsive to low oxygen tension, including vascular endothelial growth factor (VEGF), erythropoietin, and glycolytic enzymes. The activity of HIF-1alpha is regulated by binding to the transcriptional co-activator cAMP-response element-binding protein-binding protein (CBP)/p300. Using the yeast two-hybrid screening system, we found that the inhibitory domain of HIF-1alpha strongly interacted with the C-terminal domain of histone deacetylase (HDAC) 7. The o-nitrophenyl beta-d-galactopyranoside assay revealed that regions containing amino acids 735-785 of HIF-1alpha and amino acids 669-952 of HDAC7 were minimum contact sites of the interaction. The binding of HDAC7 with HIF-1alpha was reproduced in HEK293 cells grown under normoxic and hypoxic conditions (2% O(2)). HDAC7 bound solely to HIF-1alpha among other HIF-alpha family members, including HIF-2alpha and HIF-3alpha, whereas HIF-1alpha only interacted with HDAC7 in the class II HDAC family. Although HDAC7 was localized dominantly in the cytoplasm at normal oxygen concentrations, HDAC7 co-translocated to the nucleus with HIF-1alpha under hypoxic conditions. In the nucleus, HDAC7 increased transcriptional activity of HIF-1alpha through the formation of a complex with HIF-1alpha, HDAC7, and p300. Taken together, these results indicate that HDAC7 is a novel transcriptional activator of HIF-1alpha
Lu P, Deng S, Liu J, Xiao Q, Zhou Z, Li S MedComm (2020). 2024; 5(6):e576.
PMID: 38827027 PMC: 11141500. DOI: 10.1002/mco2.576.
Minisini M, Cricchi E, Brancolini C Life (Basel). 2024; 14(1).
PMID: 38276269 PMC: 10821055. DOI: 10.3390/life14010020.
Dysregulation of histone deacetylases in ocular diseases.
Jun J, Kim J, Palomera L, Jo D Arch Pharm Res. 2023; 47(1):20-39.
PMID: 38151648 DOI: 10.1007/s12272-023-01482-x.
Mitochondrial Factors in the Cell Nucleus.
Gonzalez-Arzola K, Diaz-Quintana A Int J Mol Sci. 2023; 24(17).
PMID: 37686461 PMC: 10563088. DOI: 10.3390/ijms241713656.
Targeting histone deacetylases for cancer therapy: Trends and challenges.
Liang T, Wang F, Elhassan R, Cheng Y, Tang X, Chen W Acta Pharm Sin B. 2023; 13(6):2425-2463.
PMID: 37425042 PMC: 10326266. DOI: 10.1016/j.apsb.2023.02.007.